These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29914006)

  • 21. Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer.
    Nikiteas NI; Tzanakis N; Theodoropoulos G; Atsaves V; Christoni Z; Karakitsos P; Lazaris AC; Papachristodoulou A; Klonaris C; Gazouli M
    Gastric Cancer; 2007; 10(1):12-7. PubMed ID: 17334712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvessel density is a prognostic marker of human gastric cancer.
    Zhao HC; Qin R; Chen XX; Sheng X; Wu JF; Wang DB; Chen GH
    World J Gastroenterol; 2006 Dec; 12(47):7598-603. PubMed ID: 17171787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer.
    Yu HG; Li JY; Yang YN; Luo HS; Yu JP; Meier JJ; Schrader H; Bastian A; Schmidt WE; Schmitz F
    Cancer Lett; 2003 May; 195(1):43-51. PubMed ID: 12767510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
    Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
    Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
    World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.
    Yan B; Liu L; Zhao Y; Xiu LJ; Sun DZ; Liu X; Lu Y; Shi J; Zhang YC; Li YJ; Wang XW; Zhou YQ; Feng SH; Lv C; Wei PK; Qin ZF
    World J Gastroenterol; 2014 Sep; 20(36):13105-18. PubMed ID: 25278704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.
    Chen CN; Chang CC; Su TE; Hsu WM; Jeng YM; Ho MC; Hsieh FJ; Lee PH; Kuo ML; Lee H; Chang KJ
    Ann Surg Oncol; 2009 Feb; 16(2):524-33. PubMed ID: 19050968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
    Si Y; Zhang H; Ning T; Bai M; Wang Y; Yang H; Wang X; Li J; Ying G; Ba Y
    Cell Physiol Biochem; 2017; 42(4):1670-1683. PubMed ID: 28738343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability.
    Miyamoto N; Yamamoto H; Taniguchi H; Miyamoto C; Oki M; Adachi Y; Imai K; Shinomura Y
    Cancer Lett; 2007 Aug; 254(1):42-53. PubMed ID: 17374440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
    World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer.
    Song ZJ; Gong P; Wu YE
    World J Gastroenterol; 2002 Aug; 8(4):591-5. PubMed ID: 12174362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer.
    Chen J; Zhou SJ; Zhang Y; Zhang GQ; Zha TZ; Feng YZ; Zhang K
    World J Gastroenterol; 2013 Apr; 19(13):2073-9. PubMed ID: 23599627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between the expression of vascular endothelial growth factor, fms-like tyrosine kinase-1 and biological behavior in gastric carcinoma].
    Wang YY; Ye ZY; Zhao ZS; Tao HQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):269-73. PubMed ID: 17633783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.
    Han FH; Li HM; Zheng DH; He YL; Zhan WH
    Eur J Surg Oncol; 2010 Dec; 36(12):1172-9. PubMed ID: 20888167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.
    Zhang L; Zhao ZS; Ru GQ; Ma J
    World J Gastroenterol; 2006 Jul; 12(25):3970-6. PubMed ID: 16810742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of POT1-AS1 in GC Tissue, Its Effect on Biological Behavior of Gastric Cancer, and Its Significance on Prognosis of Gastric Cancer.
    Jiang L; Yang L; Dai Y; Yang G; Pan S
    Comput Math Methods Med; 2022; 2022():6021994. PubMed ID: 35936358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer.
    McCarty MF; Wey J; Stoeltzing O; Liu W; Fan F; Bucana C; Mansfield PF; Ryan AJ; Ellis LM
    Mol Cancer Ther; 2004 Sep; 3(9):1041-8. PubMed ID: 15367698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer.
    Wei B; Shi H; Lu X; Shi A; Cheng Y; Dong L
    Mol Med Rep; 2015 Aug; 12(2):2075-81. PubMed ID: 25847144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
    Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
    Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.